Early identification of golimumab-treated patients with higher likelihood of long-term retention
11/04/2024
García-Dorta A, González-Dávila E, Sánchez-Jareño M, Cea-Calvo L, Pombo-Suárez M, Sánchez-Alonso F, Castrejón I, Díaz-González F
Frontiers in Immunology
https://doi.org/10.3389/fimmu.2024.1359571
doi: 10.3389/fimmu.2024.1359571